Financial Statements Notes to the Financial Statements 7. INVESTMENTS IN SUBSIDIARIES (continued) Non-controlling interests in subsidiaries (continued) Material NCI Other individually immaterial subsidiaries Total PLife REIT Fortis Group GHK(i) 2022 RM’000 RM’000 RM’000 RM’000 RM’000 NCI percentage of ownership interest and voting interest 64.42% 68.83% 40.00% Carrying amount of NCI 1,354,170 2,147,775(ii) (974,868) 440,003 2,967,080 Profit/(loss) allocated to NCI 147,914 213,344(iii) (84,723) (179,791) 96,744 Summarised financial information before intra-group elimination As at 31 December Non-current assets 5,196,157 5,707,481 2,166,890 Current assets 242,109 673,250 164,409 Non-current liabilities (2,903,491) (1,729,721) (4,581,935) Current liabilities (263,538) (730,698) (186,231) Net assets/(liabilities) 2,271,237 3,920,312(ii) (2,436,867) Year ended 31 December Revenue 376,199 3,374,257 868,697 Profit/(loss) for the year 230,308 294,494(iii) (211,809) Total comprehensive income/(expense) 227,418 (83,636) (214,874) Cash flows from/(used in) operating activities 300,983 384,391 (10,235) Cash flows used in investing activities (398,155) (213,955) (49,458) Cash flows from/(used in) financing activities 151,881 (204,176) 34,166 Net increase/(decrease) in cash and cash equivalents 54,709 (33,740) (25,527) Dividends paid to NCI 131,841 – – i GHK Hospital Limited (“GHK”). ii Includes net assets of RM472,197,000 attributable to NCIs within Fortis Group which are individually immaterial. iii Includes total profit of RM33,562,000 attributable to NCIs within Fortis Group which are individually immaterial. Significant restrictions PLife REIT The Group does not have significant restrictions on its ability to access or use the assets and settle the liabilities of PLife REIT other than those resulting from the regulatory framework within which the subsidiary operates. PLife REIT is regulated by the Monetary Authority of Singapore (“MAS”) and is supervised by the Singapore Exchange Securities Trading Limited (“SGX-ST”) for compliance with the Singapore Listing Rules. Under the regulatory framework, transactions with PLife REIT are either subject to review by PLife REIT’s Trustee or must be approved by a majority of votes by the remaining holders of Units in PLife REIT (“Unitholders”) at a meeting of Unitholders. The assets of PLife REIT are held in trust by a Trustee for the Unitholders. IHH Healthcare Berhad 170
RkJQdWJsaXNoZXIy NDgzMzc=